Embecta Corp. (EMBCV) Stock Analysis
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
What Embecta Corp. does
Embecta Corp. operates as a medical device company, primarily dedicated to improving the health and overall well-being of individuals living with diabetes. Its diverse product range encompasses essential items like pen needles, syringes, and various safety devices, alongside digital tools specifically designed to assist with diabetes self-management. The company distributes its offerings mainly through wholesalers and distributors, reaching customers across the United States and internationally. Embecta Corp. was established in 1924 and is headquartered in Parsippany, New Jersey.
Key metrics
ETFs linked to EMBCV
Broad-market and Healthcare sector ETFs an investor holding Embecta Corp. is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how EMBCV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze EMBCV in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Embecta Corp.?
- Embecta Corp. trades under the ticker EMBCV on NASDAQ.
- Which exchange is EMBCV listed on?
- EMBCV is listed on NASDAQ.
- What sector does Embecta Corp. operate in?
- Embecta Corp. is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
- How can PortView help analyze EMBCV in a portfolio?
- PortView shows EMBCV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.